ST宇顺(002289) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥31,315,235.36, representing a decrease of 18.95% compared to ¥38,636,661.21 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥5,272,993.53, which is a 9.76% increase in loss from ¥4,804,269.35 in the previous year[4] - The basic and diluted earnings per share were both -¥0.0188, reflecting a 9.94% increase in loss compared to -¥0.0171 in the same period last year[4] - The weighted average return on equity was -1.96%, a decrease of 0.34% from -1.62% in the previous year[4] - Total operating revenue for Q1 2022 was CNY 31,315,235.36, a decrease of 18.9% compared to CNY 38,636,661.21 in the same period last year[27] - Net loss for Q1 2022 was CNY 5,272,993.53, compared to a net loss of CNY 4,804,269.35 in Q1 2021, reflecting a decline of 9.7%[28] - The company reported a total comprehensive loss of CNY 5,272,993.53 for Q1 2022, compared to a loss of CNY 4,804,269.35 in the same period last year[29] Cash Flow and Assets - The net cash flow from operating activities improved by 32.60%, amounting to -¥12,129,537.44 compared to -¥17,997,290.74 in the previous year[4] - The company reported a net cash flow from investing activities of -¥43,112.00, a 99.91% improvement from -¥47,359,281.84 in the previous year[9] - The net cash flow from financing activities was -2,000,655.00 CNY, indicating a cash outflow[33] - The net increase in cash and cash equivalents for the period was -14,173,304.44 CNY, compared to a decrease of 65,356,572.58 CNY in the previous year[33] - The ending balance of cash and cash equivalents was 33,685,392.91 CNY, down from 97,943,894.27 CNY at the beginning of the period[33] - As of March 31, 2022, the company's total assets amounted to CNY 329,183,795.12, a decrease from CNY 359,912,085.36 at the beginning of the year[23][24] - The company's cash and cash equivalents decreased to CNY 48,068,767.30 from CNY 67,357,890.63 at the beginning of the year, representing a decline of approximately 28.8%[23] - Accounts receivable decreased to CNY 35,833,532.58 from CNY 49,250,583.19, a reduction of about 27.2%[23] - Inventory decreased to CNY 37,156,979.01 from CNY 40,140,879.46, reflecting a decline of approximately 7.4%[23] - Current liabilities decreased to CNY 50,783,229.22 from CNY 74,292,888.34, a reduction of about 31.6%[24] - The company's total liabilities decreased to CNY 62,226,054.31 from CNY 87,681,351.02 year-on-year, a reduction of 29.1%[28] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,136[12] - The largest shareholder, Zhongzhi Rongyun (Beijing) Enterprise Management Co., Ltd., holds 20.42% of the shares, totaling 57,233,855 shares[12] - Zhongzhi Industrial Investment Co., Ltd. holds 8.77% of the shares, totaling 24,585,656 shares[12] - Lin Meng, a natural person, holds 7.39% of the shares, with 20,706,000 shares pledged[12] Acquisition Plans - The company is planning to acquire 100% equity of Shenzhen Qianhai Shouke Technology Holdings Co., Ltd. through a combination of issuing shares and cash payment[14] - The stock was suspended from trading on January 21, 2021, due to the pending acquisition, and resumed trading on February 4, 2021[14] - The company received a decision from the Anti-Monopoly Bureau stating that no further review of the acquisition is required, allowing the transaction to proceed[15] - The company held a special shareholders' meeting on June 18, 2021, where the acquisition proposal was approved[16] - The company submitted the application for approval of the acquisition to the China Securities Regulatory Commission on June 29, 2021[16] - The company received feedback from the China Securities Regulatory Commission (CSRC) regarding its asset purchase and fundraising plan, which was not approved on November 16, 2021[17] - The company plans to extend the validity period of the shareholder meeting resolution for the asset purchase and fundraising by twelve months[19] - The company is actively working on the asset purchase and fundraising plan, ensuring compliance with relevant laws and regulations[19] - The company held board meetings to discuss and approve the extension of the asset purchase plan[18] - The company aims to enhance its competitive edge and sustainable profitability through the proposed transaction[18] Expenses - Sales expenses increased by 70.15% to ¥1,299,532.42 due to higher sales commissions and rewards[9] - Research and development expenses for Q1 2022 were CNY 1,126,447.37, an increase of 17.5% compared to CNY 958,876.54 in Q1 2021[28] - Sales expenses increased to CNY 1,299,532.42 in Q1 2022, up 70.0% from CNY 763,738.38 in the same period last year[28] - Total operating costs for Q1 2022 were CNY 36,687,459.04, down 16.1% from CNY 43,750,226.57 year-on-year[27]